Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

BON vs AIFU: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

BON Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 6–4 Matrix Metrics)

BON Overall Winner 6-Pillar Tally: BON 5 – 0 AIFU (1 Tie) Matrix Metrics: BON 6 – 4 AIFU

As of Nov 17, 2026, Bon Natural Life Limited Class A (BON) is the stronger overall head-to-head candidate over AIFU Inc. Class A Ordinary Share (AIFU) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BON carries a Unified Composite Score of 52.3/100 (HOLD) at $1.02 (2.4x Forward P/E, -45.5% operating margin), whereas AIFU carries 58.5/100 (HOLD) at $9.76 (18.8x Forward P/E, -220.0% operating margin).

  • Composite vs. Pillar Nuance: While AIFU currently prints a higher short-term Unified Composite Score (58.5/100 HOLD vs. BON 52.3/100 HOLD), BON captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-45.5% vs. -220.0% operating margin) and revenue trajectory (+1.9% vs. -24.0% YoY).
  • Technical & Structure Timing Caution: BON is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.4); meanwhile AIFU trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BON vs AIFU
BON NASDAQ Head-to-Head Winner
Bon Natural Life Limited Class A Ordinary Shares
Medicinal Chemicals & Botanical Products
$1.02
-5.96% 1D
Market Cap $9.0M
TTM Revenue $19M
Forward P/E 2.4x
Beta / 30D Vol -0.06β · 35% Vol
Unified Composite Score
52.3 / 100 HOLD
Tech 37.0 Fund 49.0 Flow 50.0 Mom 73.6
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.6%), weak momentum, RSI 25
RSI-14: 25.4 · SMA20: $1.12 · SMA50: $1.14
AIFU NASDAQ
AIFU Inc. Class A Ordinary Share
Insurance Agents, Brokers & Service
$9.76
-0.85% 1D
Market Cap $590.2M
TTM Revenue $485M
Forward P/E 18.8x
Beta / 30D Vol -7.07β · 88% Vol
Unified Composite Score
58.5 / 100 HOLD
Tech 79.0 Fund 63.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 47
RSI-14: 47.1 · SMA20: $9.51 · SMA50: $10.40

6-Pillar Scorecard Institutional Category Breakdown (BON 5 – 0 AIFU)

Columns: Metric · BON · AIFU
1. Valuation Multiples BON
Forward P/E 2.4x 18.8x
Trailing P/E 2.4x 20.4x
PEG Ratio N/M N/M
EV / Revenue 0.5x 1.2x
2. Growth & Scale BON
Revenue Growth (YoY) +1.9% -24.0%
Earnings Growth (YoY) -41.0% -96.8%
TTM Revenue (USD) $19M $485M
Market Cap $9.0M $590.2M
3. Profitability & Quality BON
Gross Margin 22.1% 50.9%
Operating Margin -45.5% -220.0%
Net Profit Margin -60.4% 0.0%
Return on Equity (ROE) -21.8% -112.3%
4. Balance Sheet & Cash Flow BON
Cash Generation (TTM) -$7.3M EBITDA -$1.06B EBITDA
Cash Flow Margin -38.8% EBITDA Mgn N/A
Net Cash / Leverage $8.18 Book/Sh · -21.8% ROE $25.31 Book/Sh · -112.3% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 142.0% (50th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat BON
OpEx & R&D Intensity 67.6% of Rev ($13M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Specialty Chemicals Operator Insurance Brokers Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BON (6) vs AIFU (4)
Institutional Metric BON AIFU Criterion Row Edge
Market Capitalization
Scale
$9.0M $590.2M Larger Scale AIFU
Trailing P/E Ratio
Valuation
2.4x 20.4x Lower Multiple BON
Forward P/E Ratio
Valuation
2.4x 18.8x Lower Multiple BON
Revenue Growth (YoY)
Growth
+1.9% -24.0% Higher Growth BON
Operating Margin (TTM)
Profitability
-45.5% -220.0% Higher Margin BON
Net Profit Margin
Profitability
-60.4% 0.0% Higher Margin AIFU
Return on Equity (ROE)
Capital Efficiency
-21.8% -112.3% Higher ROE BON
52-Week Range Position
Momentum
8% ($1–$2) 15% ($1–$60) Stronger Trend AIFU
Beta / 30D Volatility
Risk Regime
-0.06β · 35% Vol -7.07β · 88% Vol Lower Realized Risk BON
Unified Institutional Score
Composite Signal
52.3 / 100 (HOLD) 58.5 / 100 (HOLD) Higher Composite AIFU
Trailing 12M Revenue (USD)
Operating Scale
$19M $485M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
22.1% 50.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.5x EV/Rev N/M PEG · 1.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$7.3M EBITDA ($8.18 Book/Sh · -21.8% ROE) -$1.06B EBITDA ($25.31 Book/Sh · -112.3% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BON +3.33 pp
BON: -8.38% · AIFU: -11.71%
3M Horizon BON +11.86 pp
BON: -10.09% · AIFU: -21.95%
6M Horizon AIFU +372.23 pp
BON: -20.54% · AIFU: +351.69%
1Y Horizon AIFU +189.07 pp
BON: -45.77% · AIFU: +143.3%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BON vs AIFU. Trailing 12-month operating profitability (BON -45.5% vs AIFU -220.0%) and valuation multiples (BON 2.4x vs AIFU 18.8x Forward P/E) are benchmarked directly in Pillar 4 below.

BON ADR TTM Benchmark FX-Normalized USD
TTM Revenue$19M
Gross Margin22.1%
Op. Margin-45.5%
ROE / Fwd P/E-21.8% · 2.4x
AIFU ADR TTM Benchmark FX-Normalized USD
TTM Revenue$485M
Gross Margin50.9%
Op. Margin-220.0%
ROE / Fwd P/E-112.3% · 18.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BON UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BON Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AIFU UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 142.0%
IV Percentile 50th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AIFU Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BON Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $9.0M market capitalization and -45.5% operating margin.
OpEx & R&D Reinvestment 67.6% of Rev ($13M)
90D Engineering Disclosures 0 Published
AIFU Moat Profile Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $590.2M market capitalization and -220.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ BON vs AIFU Key Questions & Quantitative Answers

As of Nov 17, 2026, Bon Natural Life Limited Class A (BON) is the stronger overall head-to-head candidate over AIFU Inc. Class A Ordinary Share (AIFU) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BON carries a Unified Composite Score of 52.3/100 (HOLD) at $1.02 (2.4x Forward P/E, -45.5% operating margin), whereas AIFU carries 58.5/100 (HOLD) at $9.76 (18.8x Forward P/E, -220.0% operating margin). Composite vs. Pillar Nuance: While AIFU currently prints a higher short-term Unified Composite Score (58.5/100 HOLD vs. BON 52.3/100 HOLD), BON captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-45.5% vs. -220.0% operating margin) and revenue trajectory (+1.9% vs. -24.0% YoY). Technical & Structure Timing Caution: BON is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.4); meanwhile AIFU trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BON leads the Growth & Scale pillar: BON posts +1.9% YoY revenue growth and -41.0% YoY earnings growth on $19M TTM revenue (22.1% gross margin, -45.5% operating margin), compared with AIFU at -24.0% YoY revenue growth and -96.8% YoY earnings growth on $485M TTM revenue (50.9% gross margin, -220.0% operating margin). On trailing 12-month operating scale, BON generates $19M in USD-normalized revenue versus $485M for AIFU. In operating R&D and SG&A reinvestment, BON deploys 67.6% of Rev ($13M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AIFU.

BON screens cheaper on headline valuation multiples. BON trades at 2.4x Forward P/E, 2.4x Trailing P/E, N/M PEG, and 0.5x EV/Revenue (-38.8% EBITDA margin), whereas AIFU trades at 18.8x Forward P/E, 20.4x Trailing P/E, N/M PEG, and 1.2x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BON (-21.8% ROE) versus AIFU (-112.3% ROE) capital efficiency.

In options market volatility and institutional positioning, BON carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.06β · 35% Vol realized risk). By comparison, AIFU carries 142.0% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-7.07β · 88% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.